Abstract

Considered an epicenter of pandemic influenza virus generation, southern China has recently seen an increasing number of human H7N9 infections. However, it is not the only threat. On 30 November 2013, a human H10N8 infection case was first described in China. The origin and genetic diversity of this novel virus is similar to that of H7N9 virus. As H10N8 avian influenza virus (AIV) was first identified from a duck in Guangdong Province during 2012 and there is also evidence of H10N8 infected dogs in this region, we sought to examine archived sera from animal workers to see if there was evidence of subclinical human infections before the first human H10N8 cases. We studied archived serum samples (cross-sectional study, convenience sample) collected between May and September 2013 from 710 animal workers and 107 non-animal exposed volunteers living in five cities of Guangdong Province. Study participants’ sera were tested by horse red blood cells (RBCs) hemagglutination inhibition (HI) and microneutralization (MN) assays according to World Health Organization guidelines. The A/Jiangxi-Donghu/346-1/2013(H10N8) virus was used. Sera which have an HI assay ≥1:20 were further tested with the MN assay. Questionnaire data were examined for risk factor associations with positive serological assays. Risk factor analyses failed to identify specific factors associated with probable H10N8 infections. Among the 827 sera, only 21 animal workers had an HI titer ≥1:20 (18 had an HI titer of 1:20 and 3 had an HI titer of 1:40). None of these 21 subjects reported experiencing any influenza symptoms during the three months before enrollment. Among the three subjects with HI titers of 1:40, two had MN antibody titers of 1:40, and one had a MN antibody titer of 1:80 (probable H10N8 infections). Study data suggest that animal workers may have been infected with the H10N8 virus before the first recognized H10N8 human infection cases. It seems prudent to continue surveillance for H10N8 viruses among animal workers.

Highlights

  • Considered an epicenter of pandemic influenza virus generation, southern China has recently seen an increasing number of human H7N9 infections

  • It had been observed that the use of horse red blood cells (RBCs) significantly increased the sensitivity of detection of hemagglutination inhibition (HI) antibodies in the sera of confirmed H7N9 cases compared with the use of turkey RBCs, the World Health Organization recommends that horse RBCs should be used to detect HI antibodies for H7N9 virus infection [13]

  • As there was no established HI titer standard to detect a mild or asymptomatic human H10N8 infection, and the positive-control samples have shown HI antibody titers ranging from 1:40 to 1:1280, in this seroepidemiological study we considered sera with HI titers above 1:40 as having possible evidence of previous H10N8 virus infection but only those sera with both HI and MN titers ≥1:40 as having probable evidence of previous infection with influenza A(H10N8) virus

Read more

Summary

Introduction

Considered an epicenter of pandemic influenza virus generation, southern China has recently seen an increasing number of human H7N9 infections. Located in southern China, Guangdong Province is home to some of the world’s largest populations of humans, chickens, ducks and pigs and has been associated with human outbreaks of severe acute respiratory syndrome (SARS) and highly pathogenic H5N1 avian influenza infections. This region of China has been considered an epicenter of novel influenza virus generation [1,2]. The H10N8 virus emergence coincided with a second wave of the human H7N9 AIV outbreak [10], and subsequent to the human index case, more H10N8 AIV infections have been detected in both avian species and humans [3,11]

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.